Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (14252)	11/21/2004 9:12:13 AM
From: kenhott	Read Replies (2) \| Respond to of 52153

Thanks Richard and Zeta! I absolutely agree that manufacturing is going to be a major issue. Are they going to be up to the task? My personal answer is to file the concern into my mind now but don't "worry" about it till later. I see getting to a major drug as scoring a run in baseball. The company has to get all the way around the bases to make it big. At this point, I am looking at 1st base, phase 2/3 data. I learned a long time ago that investing is about making money and not about being ultimately right. I am not talking about technical investing, but positional investing. It was a HARD lesson for me to learn, got absolutely killed for a couple of years when I first started investing in the early 80s. Alxn is a good example of how I try to invest now. I have made ~$90/share on that stock and it is still trying to get pass first base. Do they have something? Likely, but I am in position to play with the house money which is one of the objectives of my personal investmenet style. One thing that helped me a great deal was when I started investing for my family and friends. Nothing focuses the mind more than having to tell a bunch of someones you care about how and what you did. If someone has a sloppy investment style, try giving your wife or husband or your 7 year old daughter :) a monthly presentation of your investments. Of course I won't tell you about the 99999 stocks that I got killed in. DNDN interests me BECAUSE it is a love/hate stock. If it runs between $5 and $15 a couple three times and I catch parts of a up and a down or some combination, I have $7-10 per shares of gains and that is more than good enough for me for a $10 stock. Brean went from a buy to a sell after the investment day. Pretty funny stuff. Did a pretty good short job on the stock which means a decent mix of facts and almost facts. Read the previous report Brean did on DNDN with the buy rating (posted on Yahoo) and you can make up your own mind about what these guys do for a living. I read from Yahoo that Ashoff was supposively the guy who was fired when he was caught impersonating a doc trying to get trial info. Just an interesting sidebar.